Biology Reference
In-Depth Information
simultaneous absence of perforin-, CD95L-, TNFR1-, and TRAIL-dependent killing.
Blood 2003;101:3991-9.
[42] Zimmerman Z, Shatry A, Deyev V, Podack E, Mammolenti M, Blazar BR, et al. Effector
cells derived from host CD8 memory T cells mediate rapid resistance against minor his-
tocompatibility antigen-mismatched allogeneic marrow grafts without participation of
perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family
effector pathways. Biol Blood Marrow Transplant 2005;11:576-86.
[43] Storb R, Prentice RL, Thomas ED. Marrow transplantation for treatment of aplas-
tic anemia. An analysis of factors associated with graft rejection. N Engl J Med
1977;296:61-6.
[44] Storb R, Prentice RL, Thomas ED, Appelbaum FR, Deeg HJ, Doney K, et al. Factors as-
sociated with graft rejection after HLA-identical marrow transplantation for aplastic
anaemia. Br J Haematol 1983;55:573-85.
[45] Storb R, Thomas ED, Buckner CD, Clift RA, Deeg HJ, Fefer A, et al. Marrow transplan-
tation in thirty “untransfused” patients with severe aplastic anemia. Ann Intern Med
1980;92:30-6.
[46] Anasetti C, Doney KC, Storb R, Meyers JD, Farewell VT, Buckner CD, et al. Marrow
transplantation for severe aplastic anemia. Long-term outcome in fifty “untransfused”
patients. Ann Intern Med 1986;104:461-6.
[47] Anasetti C, Amos D, Beatty PG, Appelbaum FR, Bensinger W, Buckner CD, et al. Effect
of HLA compatibility on engraftment of bone marrow transplants in patients with
leukemia or lymphoma. N Engl J Med 1989;320:197-204.
[48] Donohue J, Homge M, Kernan NA. Characterization of cells emerging at the time of
graft failure after bone marrow transplantation from an unrelated marrow donor. Blood
1993;82:1023-9.
[49] Garver RM, Cole LJ. Passive transfer of bone marrow homotransplantation immunity
with specific antisera. J Immunol 1961;86:307-11.
[50] Loutit JF, Micklem HS. Active and passive immunity to transplantation of foreign bone
marrow in lethally irradiated mice. Br J Exp Pathol 1961;42:577-86.
[51] Storb R, Weiden PL, Deeg HJ, Graham TC, Atkinson K, Slichter SJ, et al. Rejection of
marrow from DLA-identical canine littermates given transfusions before grafting: anti-
gens involved are expressed on leukocytes and skin epithelial cells but not on platelets
and red blood cells. Blood 1979;54:477-84.
[52] Storb R, Epstein RB, Rudolph RH, Thomas ED. The effect of prior transfusion on mar-
row grafts between histocompatible canine siblings. J Immunol 1970;105:627-33.
[53] Storb R, Rudolph RH, Graham TC, Thomas ED. The influence of transfusions from
unrelated donors upon marrow grafts between histocompatible canine siblings.
J Immunol 1971;107:409-13.
[54] Xu H, Chilton PM, Tanner MK, Huang Y, Schanie CL, Dy-Liacco M, et al. Humoral
immunity is the dominant barrier for allogeneic bone marrow engraftment in sensi-
tized recipients. Blood 2006;108:3611-9.
[55] Taylor PA, Ehrhardt MJ, Roforth MM, Swedin JM, Panoskaltsis-Mortari A, Serody JS,
et al. Preformed antibody, not primed T cells, is the initial and major barrier to bone
marrow engraftment in allosensitized recipients. Blood 2007;109:1307-15.
[56] Levesque V, Bardwell PD, Shimizu I, Haspot F, Benichou G, Yeap BY, et al. B-cell-
dependent memory T cells impede nonmyeloablative mixed chimerism induction in
presensitized mice. Am J Transplant 2011;11:2322-31.
[57] Xu H, Huang Y, Hussain LR, Zhu Z, Bozulic LD, Ding C, et al. Sensitization to minor
antigens is a significant barrier in bone marrow transplantation and is prevented by
CD154:CD40 blockade. Am J Transplant 2010;10:1569-79.
[58] Patel SR, Cadwell CM, Medford A, Zimring JC. Transfusion of minor histocompatibility
antigen-mismatched platelets induces rejection of bone marrow transplants in mice.
J Clin Invest 2009;119:2787-94.
[59] Shatry AM, Roopenian DC, Levy RB. Survival andfFunction of MiHA epitope-specific
host CD8 TM cells following ablative conditioning and HCT. Biol Blood Marrow Trans-
plant 2007;13:293-8.
[60] Warren RP, Storb R, Weiden PL, Mickelson EM, Thomas ED. Direct and antibody-
dependent cell-mediated cytotoxicity against HLA identical sibling lymphocytes.
Correlation with marrow graft rejections. Transplantation 1976;22:631-5.
[61] Spellman S, Bray R, Rosen-Bronson S, Haagenson M, Klein J, Flesch S, et al. The detec-
tion of donor-directed, HLA-specific alloantibodies in recipients of unrelated hemato-
poietic cell transplantation is predictive of graft failure. Blood 2010;115:
2704-8.
[62] Cutler C, Kim HT, Sun L, Sese D, Glotzbecker B, Armand P, et al. Donor-specific anti-
HLA antibodies predict outcome in double umbilical cord blood transplantation. Blood
2011;118:6691-7.
117
Search WWH ::
Custom Search